Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 08 symbols : PFE save search
Global Cell and Gene Therapy Market Report 2021-2027: Market Opportunities in Drug Approvals and Strong Pipeline & Increasing Number of Mergers and Acquisitions
Published: 2021-03-08 (Crawled : 13:14) - prnewswire.com
PFE | News A | $26.26 1.0% -0.08% 36M
|
Health Technology
|
| O: 0.26%
H: 1.13%
C: -0.38%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: -0.31%
ORGO | $2.98 2.76% 2.68% 1.3M
|
Finance
|
| O: 1.86%
H: 1.82%
C: -2.21%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: 0.15%
H: 1.81%
C: -0.12%
acquisition gene therapy therapy acquisitions drug merge approval gene therapies
Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
Published: 2021-03-08 (Crawled : 06:03) - globenewswire.com
PFE | News A | $26.26 1.0% -0.08% 36M
|
Health Technology
|
| O: 0.26%
H: 1.13%
C: -0.38%
disease phase 2 vaccine
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.